| Bioactivity | Dihydroberberine (Standard) is the analytical standard of Dihydroberberine. This product is intended for research and analytical applications. Dihydroberberine is a naturally occurring isoquinoline alkaloid with anti-inflammatory, anti-atherosclerotic, hypolipidemic and anti-tumor activities. Dihydroberberine inhibits the human ether-related gene (hERG) channel and significantly reduces the expression of heat shock protein 90 (Hsp90) and its interaction with hERG. Dihydroberberine also blocks the TLR4/MyD88/NF-κB signaling pathway to reduce pro-inflammatory cytokines and immunoglobulins, and has inhibitory effects on DSS (HY-116282C)-induced experimental colitis. Dihydroberberine also increases the sensitivity of lung cancer to sunitinib (HY-10255A), with synergistic efficacy. |
| CAS | 483-15-8 |
| Formula | C20H19NO4 |
| Molar Mass | 337.37 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Dihydroberberine (Standard)
CAS: 483-15-8 F: C20H19NO4 W: 337.37
Dihydroberberine (Standard) is the analytical standard of Dihydroberberine. This product is intended for research and an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.